Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Frederik van Delft

Newcastle AuthorsTitleYearFull text
Dr Hayden Bell
Dr Helen Blair
Mankaran Singh
Professor Anthony Moorman
Professor Olaf Heidenreich
et al.		Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia (Cancer Cell International, (2023), 23, 1, (202), 10.1186/s12935-023-03057-8)2025
Dr Frederik van Delft
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia2025
Dr Hayden Bell
Dr Helen Blair
Samantha Jepson Gosling
Dr Martin Galler
Dan Astley
et al.		Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia2024
Dr Dino Masic
Dr Hayden Bell
Dr Frederik van Delft
Professor Julie Irving
Selection of dormant cells during treatment of T-lineage lymphoblastic leukemia and CREB as a therapeutic target2024
Dr Frederik van Delft
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma2024
Dr Dino Masic
Kayleigh Fee
Dr Hayden Bell
Marian Case
Juan Ojeda Garcia
et al.		Hyperactive CREB subpopulations increase during therapy in pediatric B-lineage acute lymphoblastic leukemia2023
Dr Simon Bomken
Dr Amir Enshaei
Dr Ed Schwalbe
Dr Aneta Mikulasova
Dr Masood Zaka
et al.		Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement2023
Dr Hayden Bell
Dr Helen Blair
Mankaran Singh
Professor Anthony Moorman
Professor Olaf Heidenreich
et al.		Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia2023
Dr Frederik van Delft
Professor Simon Bailey
Professor Roderick Skinner
Dr Geoff Shenton
Dr Peter Carey
et al.		Unusual relapse of low hypodiploid acute lymphoblastic leukaemia in a family with Li-Fraumeni syndrome2023
Dr Frederik van Delft
Dr Stephen Owens
Dr Michael McKean
Dr Yusri Taha
Professor Sophie Hambleton
et al.		Case report: severe acute pulmonary COVID-19 in a teenager post autologous hematopoietic stem cell transplant2022
Yuzhe Shi
Melanie Beckett
Dr Helen Blair
Dr Ricky Tirtakusuma
Dr Sirintra Nakjang
et al.		Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia2021
Dr Frederik van Delft
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia2021
Dr Amir Enshaei
Dr Sirintra Nakjang
Lynne Minto
Professor Julie Irving
Beth Poole
et al.		The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia2021
Professor Anthony Moorman
Claire Schwab
Emily Winterman
Dr Frederik van Delft
Professor Christine Harrison
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion2020
Marian Case
Dr Dino Masic
Dr David Jamieson
Dr Frederik van Delft
Professor Andrew Filby
et al.		Label-Free Leukemia Monitoring by Computer Vision2020
123